Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 Signals of dose-dependent reduction in active reservoir, and viral ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Reassurances that state clinics will pick up testing are empty – the staff do not exist, and testing has not resumed. State ...

“No new HIV diagnoses should occur when we have medication today to stop the transmission of that disease.” David Ramos, Cascade Aids Project public policy manager, testified for the bill ...

The US government's sudden decision to axe funding for HIV programmes is a "wake-up call ... the head of the Africa Centres for Disease Control and Prevention (Africa CDC) issued a stark warning ...

New research has revealed that using artificial intelligence (AI) to analyse photos taken during routine diabetes eye screenings can predict whether people with type 2 diabetes are likely to develop ...

From biosecurity and vaccines for viruses such as polio, mpox and Ebola, to food supplies for famine-stricken countries and essential treatment for people living with HIV, a vast number of ...